CURE FINDERS INC

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2003

Legal Domicile

Principal Officer

JIM DEANDA

Phone

8657554913

Tax Period

2024-07-01 to 2025-06-30

CURE FINDERS INC, founded in 2003, is a small nonprofit in the Diseases & Disorders sector that reported $184K in total revenue in fiscal year 2024. Revenue surged 31% from the prior year, signaling strong growth momentum. The organization ran a surplus of $29K, a strong 16% operating margin.

Mission

TO RAISE MONEY FOR CYSTIC FIBROSIS RESEARCH.

Program Service Accomplishments

Program 1

Expenses: $150,000

CURE FINDERS RAISES MONEY TO GIVE TO CHARITIES FOR CYSTIC FIBROSIS (CF) RESEARCH. THE RECIPIENT CHARITIES RAISE MONEY FOR RESEARCH, HELP THOSE WITH CF, AND RAISE CF AWARENESS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $7,500

Program Service Revenue $0

Investment Income $688

Other Revenue $175,824

TOTAL REVENUE $184,012

Expense Breakdown

Grants Paid $150,000

Salaries & Benefits $0

Fundraising Expenses $5,181

Program Expenses $150,000

Other Expenses $5,181

TOTAL EXPENSES $155,181

Year-over-Year Comparison

	2024	2023	Change
Revenue	$184,012	$140,838	+0.3%
Expenses	$155,181	$124,093	+0.3%
Net Income	$28,831	$16,745	+0.7%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Role	Reportable Comp	Other Comp	Total
CALLIE DEANDA	DIRECTOR	Director	$0	$0	$0
BARBARA GRAY	DIRECTOR	Director	$0	$0	$0
TOLENA TROUT	DIRECTOR	Director	$0	$0	$0
WENDY ATCHLEY	PRESIDENT	Officer	$0	$0	$0
KIRK EASTIN	VICE PRESIDENT	Officer	$0	$0	$0
KELLY STAHLKE	SECRETARY	Officer	$0	$0	$0
JIM DEANDA	TREASURER	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$184,012	$155,181	$196,503	$28,831
2024	$140,838	$124,093	$167,398	$16,745
2023	$126,652	$103,705	$150,653	$22,947
2022	$111,544	$4,621	$127,706	$106,923
2021	$7,301	$68,930	$20,842	$-61,629
2021	$7,301	$73,930	$15,842	$-66,629
2020	$82,488	$103,268	$82,412	$-20,780
2019	$95,270	$5,414	$103,192	$89,856